Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-053840
Filing Date
2025-04-15
Accepted
2025-04-14 18:30:49
Documents
105
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K aplt-20241231.htm   iXBRL 10-K 3413445
2 EX-19.1 aplt-ex19_1.htm EX-19.1 141562
3 EX-23.1 aplt-ex23_1.htm EX-23.1 13461
4 EX-31.1 aplt-ex31_1.htm EX-31.1 11493
5 EX-31.2 aplt-ex31_2.htm EX-31.2 11545
6 EX-32.1 aplt-ex32_1.htm EX-32.1 6753
7 EX-32.2 aplt-ex32_2.htm EX-32.2 7502
8 GRAPHIC img211024981_0.jpg GRAPHIC 11489
9 GRAPHIC img211024981_1.jpg GRAPHIC 81537
10 GRAPHIC img211024981_2.jpg GRAPHIC 85141
11 GRAPHIC img211024981_3.jpg GRAPHIC 70176
12 GRAPHIC img211024981_4.jpg GRAPHIC 108138
13 GRAPHIC img211024981_5.jpg GRAPHIC 97156
  Complete submission text file 0000950170-25-053840.txt   13355965

Data Files

Seq Description Document Type Size
14 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT aplt-20241231.xsd EX-101.SCH 1743526
108 EXTRACTED XBRL INSTANCE DOCUMENT aplt-20241231_htm.xml XML 1762486
Mailing Address 545 FIFTH AVENUE, SUITE 1400 NEW YORK NY 10017
Business Address 545 FIFTH AVENUE, SUITE 1400 NEW YORK NY 10017 212-220-9226
Applied Therapeutics, Inc. (Filer) CIK: 0001697532 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38898 | Film No.: 25837101
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)